ResearcherThe University of TokyoActive in the last 2 years
Kohei Miyazono
Matched on ORCID iD 0000-0001-7341-0172; OpenAlex author ID A5051009186. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 17
2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- In vitro functional analysis of lysyl oxidase family members in highly metastatic pancreatic cancer cells derived from a syngeneic orthotopic model. Co-author DOI 10.1186/s12885-026-16173-1↗
- Neurotensin receptor 1 signaling promotes pancreatic cancer progression. Last author DOI 10.1002/1878-0261.12815↗
- Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells. Last author DOI 10.1038/s41388-018-0144-0↗
- Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2. Co-author DOI 10.1016/j.jconrel.2016.04.007↗
- Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1. Co-author DOI 10.1016/j.ajpath.2015.01.011↗
- Engineering fibrotic tissue in pancreatic cancer: a novel three-dimensional model to investigate nanoparticle delivery. Co-author DOI 10.1016/j.bbrc.2012.01.117↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shogo Ehata · 4 shared papers, 2015–2026 · strength 0.59
- Paper In vitro functional analysis of lysyl oxidase family members in highly metastatic pancreatic cancer cells derived from … DOI 10.1186/s12885-026-16173-1↗
- Paper Neurotensin receptor 1 signaling promotes pancreatic cancer progression. DOI 10.1002/1878-0261.12815↗
- Paper Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells. DOI 10.1038/s41388-018-0144-0↗
- Kei Takahashi · 3 shared papers, 2018–2026 · strength 0.54
- Paper In vitro functional analysis of lysyl oxidase family members in highly metastatic pancreatic cancer cells derived from … DOI 10.1186/s12885-026-16173-1↗
- Paper Neurotensin receptor 1 signaling promotes pancreatic cancer progression. DOI 10.1002/1878-0261.12815↗
- Paper Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells. DOI 10.1038/s41388-018-0144-0↗
- Manabu Kawai · 1 shared paper, 2026 · strength 0.29
- Horacio Cabral · 2 shared papers, 2012–2016 · strength 0.09
- Paper Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-a… DOI 10.1016/j.jconrel.2016.04.007↗
- Paper Engineering fibrotic tissue in pancreatic cancer: a novel three-dimensional model to investigate nanoparticle delivery. DOI 10.1016/j.bbrc.2012.01.117↗
- Mitsunobu R. Kano · 2 shared papers, 2012–2016 · strength 0.09
- Paper Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-a… DOI 10.1016/j.jconrel.2016.04.007↗
- Paper Engineering fibrotic tissue in pancreatic cancer: a novel three-dimensional model to investigate nanoparticle delivery. DOI 10.1016/j.bbrc.2012.01.117↗
- Satoshi Sakai · 1 shared paper, 2016 · strength 0.07
- Hiroyoshi Y. Tanaka · 1 shared paper, 2016 · strength 0.07
- Yukari Hoshino · 1 shared paper, 2015 · strength 0.05
- Taku Aoki · 1 shared paper, 2015 · strength 0.05
- Norihiro Kokudo · 1 shared paper, 2015 · strength 0.05
- Mitsuru Akashi · 1 shared paper, 2012 · strength 0.03
- Kazunori Kataoka · 1 shared paper, 2012 · strength 0.03
- Hitomi Hosoya · 1 shared paper, 2012 · strength 0.03
- Michiya Matsusaki · 1 shared paper, 2012 · strength 0.03
- Kazuhiko Koike · 1 shared paper, 2012 · strength 0.03
- Hideaki Ijichi · 1 shared paper, 2012 · strength 0.03
- Hiroshi Nishihara · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.